• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Intarcia raises $225m to fund diabetes trial | Medtech funding for the week of April 27, 2015

Intarcia raises $225m to fund diabetes trial | Medtech funding for the week of April 27, 2015

May 1, 2015 By MassDevice Contributors Network

Intarcia adds $225m for Type II diabetes trial

April 28, 2015 by Brad Perriello

Intarcia adds $225m for Type II diabetes trial

Intarcia Therapeutics took its total raise to more than $1 billion with a $225 million funding round it plans to use to run clinical trials and commercialize its the drug-device combination treatment it’s developing for Type II diabetes.

The debt round, involving convertible notes that pay of 1.5% of future royalties until repaid, values the company at $5.5 billion, Boston-based Intarcia said. Once its ITCA 650 treatment wins U.S. approval, investors have a 2-year window to convert the notes to Intarcia stock at the $5.5 billion valuation, the company said. Read more

Gynesonics raises $3m for VizAblate fibroid device

April 24, 2015 by Mark Hollmer

Gynesonics raises $3m for VizAblate fibroid device

California’s Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.

The Redwood City-based company, which disclosed the April 9 offering in a recent regulatory filing, is running a clinical trial for VizAblate. The device is a minimally-invasive radiofrequency ablation system designed to both image and treat fibroids within the walls of the uterus without using incisions. Read more

Lombard Medical takes out $26m loan for Aorfix stent graft

April 29, 2015 by Brad Perriello

Lombard Medical takes out $26m loan for Aorfix stent graft

Lombard Medical Technologies said it took out a $26 million term loan from Oxford Finance it plans to use in funding the global rollout of its Aorfix stent graft for treating abdominal aortic aneurysms.

Irvine, Calif.-based Lombard said it booked the 1st $11 million from the loan April 24, with another $10 million pegged to “a specific near-term revenue milestone” and the final $5 million contingent on another sales target. Read more

Alliqua prices $30m offering

April 29, 2015 by Brad Perriello

Alliqua prices $30m offering

Alliqua Biomedical said it priced a public stock offering worth $30 million for its hydrogel wound care technology.

The Langhorne, Pa.-based company said it plan to offer nearly 6.9 million shares at $4.55 apiece. Read more

Contego Medical raises $6m for embolic filter tech

April 27, 2015 by Mark Hollmer

Contego Medical raises $6m for embolic filter

Contego Medical said it pulled in $5.6 million in a Series B round to advance its embolic protection technology for angioplasty balloon and stent-delivery catheters.

The Raleigh, N.C.-based company said it plans to use the money to expand its leadership, sales and engineering teams. The money is also slated to fuel development of new products with its next-generation integrated embolic protection technology. Read more

Filed Under: Diabetes, Funding Roundup, News Well Tagged With: Alliqua Biomedical, Contego Medical, Gynesonics, Hatteras Venture Partners, Intarcia Therapeutics, lombardmedical, Lookout Capital, Medical Mutual, Mountain Group Partners, Oxford Finance

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy